Kowalsky Matthew Paul has filed 6 insider transactions across 1 company since April 2024.
Most recent transaction: a grant/award of 1318 shares of ENANTA PHARMACEUTICALS INC ($ENTA) on February 12, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 12, 2026 | ENANTA PHARMACEUTICALS INC | $ENTA | Kowalsky Matthew Paul | Chief Legal Officer | A | Common Stock | 1318 | $0.00 | 1,318.0000 | 29,019,344 | 9999.99% | 0.00% |
| Feb. 12, 2026 | ENANTA PHARMACEUTICALS INC | $ENTA | Kowalsky Matthew Paul | Chief Legal Officer | A | Common Stock | 4175 | $0.00 | 5,493.0000 | 29,019,344 | 316.77% | 0.01% |
| Feb. 12, 2026 | ENANTA PHARMACEUTICALS INC | $ENTA | Kowalsky Matthew Paul | Chief Legal Officer | F | Common Stock | 1902 | $14.25 | 3,591.0000 | 29,019,344 | 34.63% | 0.01% |
| Nov. 25, 2025 | ENANTA PHARMACEUTICALS INC | $ENTA | Kowalsky Matthew Paul | Chief Legal Officer | A | Stock Option (right to buy) | 90000 | $0.00 | 90,000.0000 | 28,862,601 | 9999.99% | 0.31% |
| Nov. 27, 2024 | ENANTA PHARMACEUTICALS INC | $ENTA | Kowalsky Matthew Paul | Chief Legal Officer | A | Stock Option (right to buy) | 75000 | $0.00 | 75,000.0000 | 0 | 9999.99% | 0.00% |
| April 29, 2024 | ENANTA PHARMACEUTICALS INC | $ENTA | Kowalsky Matthew Paul | Chief Legal Officer | A | Stock Option (right to buy) | 150000 | $0.00 | 150,000.0000 | 0 | 9999.99% | 0.00% |